MLchartDataset catalogue

Hemangeol

Term · Oncology and biomedicine · MLC-T-ONC-003765

A drug that contains the active ingredient propranolol hydrochloride and is used to treat infants 5 weeks to 5 months of age with infantile hemangioma (a benign blood vessel tumor). It is also being studied in the treatment of other conditions and some types of cancer. Hemangeol may help shrink certain types of vascular tumors. It is a type of beta blocker.

Table 1. Record
IdentifierMLC-T-ONC-003765
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-003765",
  "term": "Hemangeol",
  "field": "Oncology and biomedicine",
  "definition": "A drug that contains the active ingredient propranolol hydrochloride and is used to treat infants 5 weeks to 5 months of age with infantile hemangioma (a benign blood vessel tumor). It is also being studied in the treatment of other conditions and some types of cancer. Hemangeol may help shrink certain types of vascular tumors. It is a type of beta blocker.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/hemangeol/"
}

Record 8,331 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.